Could This Be the First Parkinson's Disease Modifier?

Episode notes

Send us Fan Mail Is the era of just managing Parkinson's symptoms finally coming to an end? In this clip from our episode “How AI Is Helping The Fight Against Parkinson’s”, host David E. Williams and guest Gene Mack, CEO of Gain Therapeutics, share why the early signals from their lead drug candidate are too compelling to ignore. Listen to the full episode here ️️ABOUT GENE MACK Gene Mack serves as Chief Executive Officer and President of Gain Therapeutics. He joined the Company in April 2024 and brings 25 years of experience in the life sciences sector spanning clinical research, financing and capital markets, investing, corporate strategy and business development. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023. Previous to Imcyse, Gene was CFO at OncoC4, a privately held biotechnology company that spun out of Merck & Co’s (MSD) $475 million acquisition of OncoImmune in 2020 where he had also been CFO. Before that, he has held the CFO role for several development- and commercial-stage biopharmaceutical companies, raising over $350 million in IPO and other equity transactions.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Michelle Gill: AI-Assisted Drug Discovery, NVIDIA, Biofoundation Models, Creating Applied Research Teams | Learning from Machine Learning #8Learning from Machine Learning · on Drug Discovery88 / 100
• Success Leaves Clues: Ep 296 How Healthcare Innovation Improves Patient Access with John Leombruno, CEO at OkRx Success Leaves Clues with Robin Bailey and Al McDonald · on healthcare podcast79 / 100
• This Just In Radio: AI in Action with Tony Nunes of AMDThis Just In Radio Show · on Drug Discovery64 / 100
• Decoding AQ with Ross Thornley Feat. Lisa Hammond - Chief Human Resources Officer at VeradigmDECODING AQ · on Drug Discovery64 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-ColtonProgress, Potential, and Possibilities Podcast / Show · on Drug Discovery
• From the Gap in Healthcare to a MovementWhat The Tech? · on healthcare

• AI and The Future Of Behavioral Health w/ Alon Joffe, Co-Founder & CEO, Eleos Health88 / 100
• How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio Therapeutics94 / 100
• Preparing for the Pandemic We Haven't Seen Yet w/ Dr. Dan Barouch & Kris Brown, Vector Sciences87 / 100
• Mark Cuban on Why Patients Don’t Trust Their Medical Bills85 / 100
• Why Healthcare Prices Are Like Fight Club w/ Mark Cuban, Co-Founder, Cost Plus Drugs100 / 100